Goldman Sachs’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$42.6M Buy
148,198
+71,842
+94% +$20.6M 0.01% 1228
2025
Q1
$23.5M Sell
76,356
-19,979
-21% -$6.16M ﹤0.01% 1578
2024
Q4
$34M Buy
96,335
+18,997
+25% +$6.7M 0.01% 1348
2024
Q3
$27.7M Sell
77,338
-3,372
-4% -$1.21M ﹤0.01% 1483
2024
Q2
$25.7M Buy
80,710
+22,234
+38% +$7.08M ﹤0.01% 1420
2024
Q1
$13.4M Sell
58,476
-47,653
-45% -$10.9M ﹤0.01% 1828
2023
Q4
$23.3M Sell
106,129
-9,060
-8% -$1.99M ﹤0.01% 1451
2023
Q3
$26M Sell
115,189
-71,814
-38% -$16.2M 0.01% 1320
2023
Q2
$41.3M Buy
187,003
+51,557
+38% +$11.4M 0.01% 1062
2023
Q1
$30.3M Sell
135,446
-176,693
-57% -$39.6M 0.01% 1226
2022
Q4
$86.8M Buy
312,139
+117,912
+61% +$32.8M 0.02% 674
2022
Q3
$40.7M Sell
194,227
-13,265
-6% -$2.78M 0.01% 1092
2022
Q2
$48.9M Buy
207,492
+34,164
+20% +$8.05M 0.01% 985
2022
Q1
$31.1M Buy
173,328
+4,255
+3% +$763K 0.01% 1416
2021
Q4
$36.5M Sell
169,073
-113,763
-40% -$24.6M 0.01% 1341
2021
Q3
$52.2M Buy
282,836
+81,882
+41% +$15.1M 0.01% 1076
2021
Q2
$36.1M Sell
200,954
-122,411
-38% -$22M 0.01% 1312
2021
Q1
$54.1M Sell
323,365
-63,376
-16% -$10.6M 0.01% 993
2020
Q4
$58.7M Sell
386,741
-45,171
-10% -$6.86M 0.02% 858
2020
Q3
$43.6M Buy
431,912
+197,884
+85% +$20M 0.01% 951
2020
Q2
$28.3M Sell
234,028
-246,515
-51% -$29.8M 0.01% 1237
2020
Q1
$45.6M Buy
480,543
+113,845
+31% +$10.8M 0.02% 843
2019
Q4
$32.3M Buy
366,698
+106,157
+41% +$9.35M 0.01% 1301
2019
Q3
$20.8M Sell
260,541
-406,233
-61% -$32.4M 0.01% 1495
2019
Q2
$52M Sell
666,774
-152,619
-19% -$11.9M 0.02% 995
2019
Q1
$96.2M Sell
819,393
-100,472
-11% -$11.8M 0.03% 631
2018
Q4
$100M Sell
919,865
-198,776
-18% -$21.6M 0.03% 560
2018
Q3
$143M Buy
1,118,641
+198,097
+22% +$25.3M 0.04% 504
2018
Q2
$104M Sell
920,544
-104,246
-10% -$11.8M 0.03% 644
2018
Q1
$115M Sell
1,024,790
-6,444
-0.6% -$724K 0.03% 629
2017
Q4
$153M Sell
1,031,234
-103,445
-9% -$15.3M 0.04% 514
2017
Q3
$133M Sell
1,134,679
-440,736
-28% -$51.6M 0.03% 552
2017
Q2
$204M Buy
1,575,415
+420,594
+36% +$54.6M 0.05% 337
2017
Q1
$156M Buy
1,154,821
+282,955
+32% +$38.3M 0.04% 415
2016
Q4
$125M Buy
871,866
+76,227
+10% +$10.9M 0.04% 513
2016
Q3
$93.9M Sell
795,639
-257,614
-24% -$30.4M 0.03% 630
2016
Q2
$112M Buy
1,053,253
+82,735
+9% +$8.76M 0.04% 503
2016
Q1
$108M Buy
970,518
+54,830
+6% +$6.11M 0.04% 534
2015
Q4
$143M Buy
915,688
+390,383
+74% +$61.1M 0.05% 394
2015
Q3
$68.9M Sell
525,305
-6,201
-1% -$814K 0.02% 645
2015
Q2
$92.5M Buy
531,506
+69,672
+15% +$12.1M 0.03% 558
2015
Q1
$79.6M Buy
461,834
+173,206
+60% +$29.9M 0.03% 614
2014
Q4
$37.4M Sell
288,628
-40,168
-12% -$5.2M 0.01% 981
2014
Q3
$42.3M Sell
328,796
-231,207
-41% -$29.7M 0.01% 877
2014
Q2
$49.6M Buy
560,003
+173,845
+45% +$15.4M 0.02% 819
2014
Q1
$36.3M Sell
386,158
-116,385
-23% -$10.9M 0.01% 938
2013
Q4
$56.8M Buy
502,543
+113,585
+29% +$12.8M 0.02% 704
2013
Q3
$30.7M Sell
388,958
-29,565
-7% -$2.33M 0.01% 925
2013
Q2
$27.5M Buy
+418,523
New +$27.5M 0.01% 907